Human Chorionic Gonadotropin Market Size, Share, Trends, Market Growth, AnalysisPosted by akshayparmar on November 14th, 2017 Human Chorionic Gonadotropin Market (Treatments: Female Infertility, Oligospermia, Cryptorchidism & Others; Technology: Natural Source Extraction & Recombinant DNA Technology): Growth, Future Prospects and Competitive Analysis, 2016-2022, the human chorionic gonadotropin market was valued at USD346.3 Mn in 2015, and is expected to reach USD533.7Mn by 2022, expanding at a CAGR of 6% from 2016 to 2022. Browse Full Report Visit - http://www.acutemarketreports.com/report/human-chorionic-gonadotropin-market Market Insights North America constitutes regional markets of U.S.and Canada, the rising incidence of infertility cases, lifestyle effects and others,hormonal dysfunctions in men and women are the major driver for the growth ofthe global human chorionic gonadotropin market. Asia-Pacific is the expected to bethe most potential regional market for human chorionic gonadotropin market by2022. Over the next six years, the growth of the market in the Asia-Pacific region islikely to be centered in Japan, South Korea, China, and India.The key players in human chorionic gonadotropin market are EMD Serono, Inc.,Ferring B.V., Merck & Co., Inc., Bristol Myers Squibb Company and Fresenius KabiUSA, LLC.
Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Global Hematopoietic Stem Cells Market Overview About - Acute Market Reports : Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online. Name : Chris Paul ACUTE MARKET REPORTS Designation : Global Sales Manager Toll Free(US/CANADA): +1-855-455-8662 Email : sales@acutemarketreports.com Website :http://www.acutemarketreports.com Like it? Share it!More by this author |